Cummings, Jeffrey
Article History
First Online: 19 August 2021
Competing interests
: J.C. has provided consultation to Acadia, Alkahest, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Cassava, Cerecin, Cerevel, Cortexyme, EIP Pharma, Eisai, GemVax, Genentech, Green Valley, Grifols, Janssen, Jazz, Karuna, LSP, Merck, Novo Nordisk, Otsuka, ReMYND, Resverlogix, Roche, Signant Health, Sunovion, Suven, United Neuroscience, and Unlearn AI pharmaceutical and assessment companies. J.C. owns the copyright to the Neuropsychiatric Inventory. J.C. has research support from the National Institute of General Medical Sciences, the National Institute of Neurological Disorders and Stroke, and the National Institute on Aging.